Abstract:Human immunodeficiency virus type-1 (HIV-1) infection has resulted in the death of upward of 39 million people since being discovered in the early 1980s. A cure strategy for HIV-1 has eluded scientists, but gene editing technologies such as clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) offer a new approach to developing a cure for HIV infection. While the CRISPR/Cas9 system has been used successfully in a number of different types of studies, there remains a concern for off-target effects. This review details the different aspects of the Cas9 system and how they play a role in off-target events. In addition, this review describes the current technologies available for detecting off-target cleavage events and their advantages and disadvantages. While some studies have utilized whole genome sequencing (WGS), this method sacrifices depth of coverage for interrogating the whole genome. A number of different approaches have now been developed to take advantage of next generation sequencing (NGS) without sacrificing depth of coverage. This review highlights four widely used methods for detecting off-target events: (1) genome-wide unbiased identification of double-stranded break events enabled by sequencing (GUIDE-Seq), (2) discovery of in situ Cas off-targets and verification by sequencing (DISCOVER-Seq), (3) circularization for in vitro reporting of cleavage effects by sequencing (CIRCLE-Seq), and (4) breaks labeling in situ and sequencing (BLISS). Each of these technologies has advantages and disadvantages, but all center around capturing double-stranded break (DSB) events catalyzed by the Cas9 endonuclease. Being able to define off-target events is crucial for a gene therapy cure strategy for HIV-1.

Mitigating the Off-target Effects in CRISPR/Cas9-mediated Genetic Editing with Bioinformatic Technologies

Mitigating off-target effects in CRISPR/Cas9-mediated in vivo gene editing

Off-target effects in CRISPR/Cas9 gene editing

Off-target Effects in CRISPR/Cas9-mediated Genome Engineering

Recent Advancements in Reducing the Off-Target Effect of CRISPR-Cas9 Genome Editing

The Challenge Facing CRISPR/Cas9 System: Off-Target Effects and Their Optimization

Off-target Effect of CRISPR/Cas9 and Optimization

Beyond the promise: evaluating and mitigating off-target effects in CRISPR gene editing for safer therapeutics

Approaches to Reduce CRISPR Off-Target Effects for Safer Genome Editing

Latest Developed Strategies to Minimize the Off-Target Effects in CRISPR-Cas-Mediated Genome Editing

Designing Safer CRISPR/Cas9 Therapeutics for HIV: Defining Factors That Regulate and Technologies Used to Detect Off-Target Editing

Prediction of off-target effects of the CRISPR/Cas9 system for design of sgRNA

CRISPR/Cas Systems in Genome Editing: Methodologies and Tools for sgRNA Design, Off‐Target Evaluation, and Strategies to Mitigate Off‐Target Effects

Molecular mechanisms, off‐target activities, and clinical potentials of genome editing systems

Current Bioinformatics Tools to Optimize CRISPR/Cas9 Experiments to Reduce Off-Target Effects

Advances in the Engineering of the Gene Editing Enzymes and the Genomes: Understanding and Handling the Off-Target Effects of CRISPR/Cas9.

Keeping CRISPR/Cas On-Target.

Targeting Specificity of the CRISPR/Cas9 System.

Strategies for High-Efficiency Mutation Using the CRISPR/Cas System

sgRNA design for the CRISPR/Cas9 system and evaluation of its off-target effects

Non-viral and Viral Delivery Systems for CRISPR-Cas9 Technology in the Biomedical Field